Friday 06 December, Nottingham, England UK. At a black-tie event held in Nottingham last night, 200 leading names and rising stars of the life sciences came together at the Medilink East Midlands Business Awards 2019. A celebration of innovation within the region, a total of seven...
We are excited to announce the collaboration with 3D Biotechnology Solutions (3DBS), the leading 3D bioprinting and electrospinning technologies manufacturer in Brazil. This collaboration is part of Biogelx international growth strategy program and aims to target public and private research institutes, universities and research consortiums in...
Cheshire UK, 29 August 2019 BioCity, the pioneering life science incubator and business collective, has today announced investment in precision medicine biotech, Kinomica Ltd., via the Innovate UK Precision Medicine Investment Accelerator. Spun out from Barts Cancer Institute, Queen Mary University of London, Kinomica Ltd is an...
Platelet specialists Dr Natalia Dovlatova, Ann White and Bob Humphries announce the launch of their new company – ‘Platelet Services Limited’, which will be based in BioCity Nottingham, UK. Collectively, the team has decades of experience in the application of platelet function testing to drug...
Nottingham, UK – 02 May 2019 BioCity, a pioneering life science incubator and business collective, today announced investment in INCUS Performance, further solidifying their position as a keen investor in promising ventures. Founded in 2016, INCUS Performance is a sports technology start-up that is helping athletes to...
BioCity, a pioneering life science incubator and business collective, today announced investment in Deep Branch Biotechnology, a Nottingham-based carbon recycling start-up, developing technology that transforms polluters into producers. Unlike traditional carbon storage technology that simply collects and stores carbon dioxide, Deep Branch’s carbon recycling solution converts...
21 January 2019: BGF has made its fourth life sciences investment in the last few months, providing Nottingham-based business incubator BioCity with development capital, alongside Blue Skies Investments (BSI). Founded in 2002 and a pioneer in the field, BioCity is the UK’s largest life science incubation business, providing...
BioCity, Alderley Park based Cresset, innovative provider of software and contract research services for small molecule discovery and design, is pleased to announce that Cancer Research UK Manchester Institute (CRUK MI), has licensed Flare for fresh insights into structure-based drug design. “Putting easy-to use and visually...
BioCity, the Nottingham-headquartered life sciences incubation business, has appointed Stuart Henderson to the Board to help drive its growth and further strengthen its connections within the life sciences sector. Home to more than 200 life science and healthcare companies, BioCity was founded in 2002 and now...